Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fibrates in the treatment of dyslipidemias--time for a reassessment.

× No keyword cloud information.

20 in total

Review 1. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors: Richard Kones
Journal: Vasc Health Risk Manag Date: 2013-10-21

Review 2. Consensus statement on management of dyslipidemia in Indian subjects.

Authors: K Sarat Chandra; Manish Bansal; Tiny Nair; S S Iyengar; Rajeev Gupta; Subhash C Manchanda; P P Mohanan; V Dayasagar Rao; C N Manjunath; J P S Sawhney; Nakul Sinha; A K Pancholia; Sundeep Mishra; Ravi R Kasliwal; Saumitra Kumar; Unni Krishnan; Sanjay Kalra; Anoop Misra; Usha Shrivastava; Seema Gulati
Journal: Indian Heart J Date: 2014-12-24

Review 3. The "New Deadly Quartet" for cardiovascular disease in the 21st century: obesity, metabolic syndrome, inflammation and climate change: how does statin therapy fit into this equation?

Authors: Michael Clearfield; Melissa Pearce; Yasmin Nibbe; David Crotty; Alesia Wagner
Journal: Curr Atheroscler Rep Date: 2014-01 Impact factor: 5.113

4. 2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors: Massimo F Piepoli
Journal: Int J Behav Med Date: 2017-06

Review 5. HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.

Authors: C R Sirtori; M Ruscica; L Calabresi; G Chiesa; R Giovannoni; J J Badimon
Journal: Ann Med Date: 2019 Nov - Dec Impact factor: 4.709

Review 6. Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Authors: Richard Kones; Umme Rumana
Journal: Drugs Date: 2015-07 Impact factor: 9.546

Review 7. Revisiting the links between glycaemia, diabetes and cardiovascular disease.

Authors: N Sattar
Journal: Diabetologia Date: 2013-01-27 Impact factor: 10.122

Review 8. Management of low levels of high-density lipoprotein-cholesterol.

Authors: Amit V Khera; Jorge Plutzky
Journal: Circulation Date: 2013-07-02 Impact factor: 29.690

Review 9. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Authors: Cecilia C Low Wang; Connie N Hess; William R Hiatt; Allison B Goldfine
Journal: Circulation Date: 2016-06-14 Impact factor: 29.690

10. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors: Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal: Eur Heart J Date: 2016-05-23 Impact factor: 29.983